Search

Search bills, members, committees and pages...

Sign In

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER

PreviousNext

6 federal lobbying filings, 2025 to 2026.

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER is a client on 6 federal lobbying filings, 2025 to 2026, reporting $150K across them. Distribution Based in Texas.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

1 it has hired, by filings.

RegistrantFilingsReported
NORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC6$150K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$60K—
20254$90K—

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues6
MMMMedicare/Medicaid6
PHAPharmacy6
MANManufacturing5
TARTariff (miscellaneous tariff bills)1
TAXTaxation/Internal Revenue Code1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 2484Seniors’ Access to Critical Medications Act of 20256
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.5
H.R. 2120ROCR Value Based Program Act5
H.R. 2444Promoting Resilient Supply Chains Act of 20255
H.R. 3164Ensuring Community Access to Pharmacist Services Act5
H.R. 3514Improving Seniors’ Timely Access to Care Act of 20255
H.R. 3521Clinical Trial Modernization Act5
H.R. 879Medicare Patient Access and Practice Stabilization Act of 20255
S. 1816Improving Seniors’ Timely Access to Care Act of 20255
S. 257Promoting Resilient Supply Chains Act of 20255
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act4
H.R. 2474Expanding Appalachia’s Broadband Access Act1
H.R. 2630Youth Suicide Prevention Research Act1
H.R. 3561FORCE Act1
H.R. 4011Community Paramedicine Act of 20251
H.R. 4473BIRD Health Act of 20251
S. 1339Stop CCP Money Laundering Act of 20251
S. 652Protecting Patients from Deceptive Drug Ads Act1

Lobbyists

Named on the filings.

LobbyistClientsFilings
ERIC SILVA16
REILLY O'CONNOR15

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC2026 second_quarter$30KJul 17, 2026
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC2026 first_quarter$30KApr 20, 2026
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC2025 fourth_quarter$30KJan 19, 2026
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC2025 third_quarter$30KOct 21, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC2025 second_quarter$30KJul 21, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC2025 second_quarter—Apr 22, 2025